STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $22.27 billion. The enterprise value is $24.57 billion.
| Market Cap | 22.27B |
| Enterprise Value | 24.57B |
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Nov 19, 2024 |
Share Statistics
STERIS has 98.62 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Shares Outstanding | 98.62M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 99.48% |
| Float | 98.25M |
Valuation Ratios
The trailing PE ratio is 56.01 and the forward PE ratio is 24.02.
| PE Ratio | 56.01 |
| Forward PE | 24.02 |
| PS Ratio | 4.26 |
| Forward PS | 3.94 |
| PB Ratio | 3.51 |
| P/FCF Ratio | 37.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.26, with an EV/FCF ratio of 41.36.
| EV / Earnings | 61.42 |
| EV / Sales | 4.69 |
| EV / EBITDA | 18.26 |
| EV / EBIT | 26.65 |
| EV / FCF | 41.36 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.33 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 1.76 |
| Debt / FCF | 4.18 |
| Interest Coverage | 6.47 |
Financial Efficiency
Return on equity (ROE) is 8.97% and return on invested capital (ROIC) is 6.35%.
| Return on Equity (ROE) | 8.97% |
| Return on Assets (ROA) | 5.52% |
| Return on Capital (ROIC) | 6.35% |
| Revenue Per Employee | $287,960 |
| Profits Per Employee | $22,008 |
| Employee Count | 18,179 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 4.02 |
Taxes
In the past 12 months, STERIS has paid $148.64 million in taxes.
| Income Tax | 148.64M |
| Effective Tax Rate | 20.90% |
Stock Price Statistics
The stock price has increased by +3.95% in the last 52 weeks. The beta is 0.85, so STERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +3.95% |
| 50-Day Moving Average | 233.43 |
| 200-Day Moving Average | 226.09 |
| Relative Strength Index (RSI) | 46.48 |
| Average Volume (20 Days) | 525,842 |
Short Selling Information
The latest short interest is 1.43 million, so 1.46% of the outstanding shares have been sold short.
| Short Interest | 1.43M |
| Short Previous Month | 1.46M |
| Short % of Shares Out | 1.46% |
| Short % of Float | 1.46% |
| Short Ratio (days to cover) | 3.25 |
Income Statement
In the last 12 months, STERIS had revenue of $5.23 billion and earned $400.09 million in profits. Earnings per share was $4.03.
| Revenue | 5.23B |
| Gross Profit | 2.28B |
| Operating Income | 921.86M |
| Pretax Income | 550.80M |
| Net Income | 400.09M |
| EBITDA | 1.35B |
| EBIT | 921.86M |
| Earnings Per Share (EPS) | $4.03 |
Balance Sheet
The company has $198.33 million in cash and $2.48 billion in debt, giving a net cash position of -$2.29 billion or -$23.18 per share.
| Cash & Cash Equivalents | 198.33M |
| Total Debt | 2.48B |
| Net Cash | -2.29B |
| Net Cash Per Share | -$23.18 |
| Equity (Book Value) | 6.37B |
| Book Value Per Share | 64.32 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was $995.89 million and capital expenditures -$401.81 million, giving a free cash flow of $594.08 million.
| Operating Cash Flow | 995.89M |
| Capital Expenditures | -401.81M |
| Free Cash Flow | 594.08M |
| FCF Per Share | $6.02 |
Margins
Gross margin is 43.60%, with operating and profit margins of 17.61% and 7.64%.
| Gross Margin | 43.60% |
| Operating Margin | 17.61% |
| Pretax Margin | 13.59% |
| Profit Margin | 7.64% |
| EBITDA Margin | 25.70% |
| EBIT Margin | 17.61% |
| FCF Margin | 11.72% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 1.01%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | 10.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 56.55% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.49% |
| Earnings Yield | 1.80% |
| FCF Yield | 2.67% |
Analyst Forecast
The average price target for STERIS is $253.00, which is 12.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $253.00 |
| Price Target Difference | 12.04% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 7.13% |
| EPS Growth Forecast (5Y) | 26.89% |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 4.74 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | 7 |